MAML2 Antibody (monoclonal) (M03)
Mouse monoclonal antibody raised against a partial recombinant MAML2.
- 产品详情
- 实验流程
Application ![]()
| WB, E |
---|---|
Primary Accession | Q8IZL2 |
Other Accession | NM_032427 |
Reactivity | Human |
Host | mouse |
Clonality | monoclonal |
Isotype | IgG2a Kappa |
Clone Names | 4A1 |
Calculated MW | 125197 Da |
Gene ID | 84441 |
---|---|
Other Names | Mastermind-like protein 2, Mam-2, MAML2, KIAA1819 |
Target/Specificity | MAML2 (NP_115803, 796 a.a. ~ 894 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
Dilution | WB~~1:500~1000 E~~N/A |
Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
Precautions | MAML2 Antibody (monoclonal) (M03) is for research use only and not for use in diagnostic or therapeutic procedures. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
REFERENCES
A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas. Seethala RR, et al. Am J Surg Pathol, 2010 Aug. PMID 20588178.Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Rose JE, et al. Mol Med, 2010 Jul-Aug. PMID 20379614.Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma. Nakayama T, et al. Mod Pathol, 2009 Dec. PMID 19749740.Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases. Miyabe S, et al. J Oral Maxillofac Surg, 2009 Jul. PMID 19531414.A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma. Fehr A, et al. Genes Chromosomes Cancer, 2009 Sep. PMID 19521953.

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.